Safety and immunogenicity of heterologous Ad26.ZEBOV and MVA-BN®-Filo prime-boost Ebola vaccines: 6-month follow-up of a Phase I randomized trial in healthy adults

Saved in:
Bibliographic Details
Published inJournal of Virus Eradication Vol. 2; pp. 10 - 11
Main Authors Douoguih, Macaya, Goldstein, Neil, Bart, Stephan, Luhn, Kerstin, Van Duijnhoven, Wilbert, Truyers, Carla, Callendret, Benoit
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.05.2016
Elsevier
Online AccessGet full text

Cover

More Information
ISSN:2055-6640
DOI:10.1016/S2055-6640(20)31129-8